Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2019
Pharma News, 2019
E&C Leaders Request Information on Skyrocketing Cost of Insulin from pharmaceutical companies
“Despite the fact that it has been available for decades, prices for insulin have skyrocketed in recent years, putting it out of reach for many patients.
Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retinal Diseases
RARITAN, N.
What you eat could impact your brain and memory
AMES, Iowa - You may be familiar with the saying, "You are what you eat," but did you know the food you eat could impact your memory?Auriel Willette, assistant professor, and his team of res...
Pfizer's Xtandi blows by Johnson & Johnson's Erleada with hot start in new prostate cancer field
Pfizer's Xtandi pulled in $189 million in fourth-quarter.
Samsung BioLogics sees sales rise but profit fall as it continues expansion
Samsung BioLogics built three biologics manufacturing plants in South Korea in seven years.
£1.5million investment in Parkinson’s drug discovery
Parkinson’s UK says it intends to invest a further £1.
Pfizer inaugurates pay-for-performance in China with money-back Ibrance deal
Lately, every day seems to bring new talk about "innovative" payment models for expensive drugs in the U.
Novo Nordisk stockpiling over double usual amount ahead of Brexit
Novo Nordisk says it has planned for all future ‘no-deal’ Brexit contingencies, including doubling UK stock to 16 weeks (around four months of supply), which will be in place by the end of...
Takeda’s Dengue Vaccine Candidate Meets Primary Endpoint in Pivotal Phase 3 Efficacy Trial
Cambridge, Mass.
Global medicine spend forecast to exceed $1.5 trillion by 2023
A new report containing the latest predictions for the global pharmaceutical market has found that global spending on medicines is set to exceed $1.
Biogen beats estimates on multiple sclerosis drugs sales
(Reuters) - Biogen Inc beat analysts’ estimates for fourth-quarter profit and revenue on Tuesday, buoyed by higher sales of its top-selling multiple sclerosis drugs, and forecast full-year p...
Israeli cabinet approves law to allow medical cannabis exports
JERUSALEM (Reuters) - Israel’s cabinet approved on Sunday a law to allow exports of medical cannabis in a move expected to boost state revenues and the agriculture sector, and which frustrat...
54
55
56
57
58
59
60
61
62
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds